Academic Community's Efforts to Guide the Fight Against Coronavirus Disease 2019 (COVID-19) Epidemic in Korea.

Academic Community's Efforts to Guide the Fight Against Coronavirus Disease 2019 (COVID-19) Epidemic in Korea. J Prev Med Public Health. 2020 Mar;53(2):65-66 Authors: Cho SI PMID: 32268457 [PubMed - as supplied by publisher]
Source: Journal of Preventive Medicine and Public Health - Category: International Medicine & Public Health Tags: J Prev Med Public Health Source Type: research

Related Links:

Test and tracing is launching today but, as the lockdown eases, it will need to be massively stepped up to have a significant impact David Hunter is professor of epidemiology at the University of OxfordCoronavirus – latest updatesSee all our coronavirus coverageWe all now know the basics – the R is the average number of people someone infected with Covid-19 passes the virus on to. If it is greater than 1.0 the epidemic will grow exponentially. If it isless than 1.0 it will eventually disappear. There are several types of R: the R0 that applies to a naive population with no immunity or interventio...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus outbreak Science UK news Infectious diseases Source Type: news
In Washington State and Italy, the first confirmed cases were not linked to the outbreaks that followed, the analysis found. The epidemics were seeded later.
Source: NYT Health - Category: Consumer Health News Authors: Tags: your-feed-science Coronavirus (2019-nCoV) Genetics and Heredity Epidemics Hutchinson, Fred, Cancer Research Center Seattle-Tacoma International Airport University of Arizona University of Washington Worobey, Michael G (1970- ) Europe I Source Type: news
Publication date: Available online 27 May 2020Source: Medical Journal Armed Forces IndiaAuthor(s): Seema Patrikar, Deepti Poojary, D.R. Basannar, Renuka Kunte
Source: Medical Journal Armed Forces India - Category: General Medicine Source Type: research
COVID-19 is caused by the Severe Acute Respiratory Syndrome (SARS) coronavirus (Cov)-2, an enveloped virus with a positive-polarity, single-stranded RNA genome. The initial outbreak of the pandemic began in December 2019, and it is affecting the human health of the global community. In common with previous pandemics (Influenza H1N1 and SARS-CoV) and the epidemics of Middle east respiratory syndrome (MERS)-CoV, CoVs target bronchial and alveolar epithelial cells. Virus protein ligands (e.g., haemagglutinin or trimeric spike glycoprotein for Influenza and CoV, respectively) interact with cellular receptors, such as (dependin...
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
AbstractSince the end of 2019, a new coronavirus strain has been reported in the Chinese province of Wuhan, indicated as 2019-nCoV or SARS-CoV-2. In February 2020, the first case of transmission on Italian soil was reported. On March 09, 2020, at the time of protocol design, the Italian Ministry of Health reported 10,149 people who had contracted the virus; of these, 8514 were positive, of which 5038 were hospitalized with symptoms (59.2%) and 877 in intensive care (10.3%), while the remaining 2599 were in home isolation; 631 were deceased (6.2%) and 1004 healed (9.9%). To date there are no studies in the literature that d...
Source: Internal and Emergency Medicine - Category: Emergency Medicine Source Type: research
Yehua Shen, Chien-shan Cheng, Peng Wang, Xu Zhu, Guangyan Lei, Yong Fang, Hailiang Li, Weijun Fan, Hongming Pan, Zhe Tang, Kuansheng Ma, Xiaoguang Li, Zhengyu Lin, Yiping Zhuang, Xin Ye, Bo Zhai, Yue Han, Jinhua Huang, Huixiong Xu, Rongqin Zheng, Rufu Chen, Jie Yu, Dong Xu, Zhongmin Wang, Zhiqiang MengJournal of Cancer Research and Therapeutics 2020 16(2):350-355 The coronavirus disease 2019 (COVID-19) has become a global pandemic since its outbreak in December 2019, which posed a threat to the safety and well-being of people on a global scale. Cancer patients are at high risk of severe acute respiratory syndrome coronavi...
Source: Journal of Cancer Research and Therapeutics - Category: Cancer & Oncology Authors: Source Type: research
A number of pneumonia cases of unknown causes have emerged in Wuhan, Hubei, China since December 2019.1 After sequencing analysis of samples from the lower respiratory tract, a coronavirus,2 which was last named as severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).3 On February 11, 2020, the World Health Organization (WHO) announced a new name for the disease caused by 2019-nCoV: coronavirus disease 2019 (COVID-19).4 With the arrival of the Spring Festival, an epidemic SARS-CoV-2 infection has spread rapidly.
Source: Journal of Infection - Category: Infectious Diseases Authors: Tags: Letter to the Editor Source Type: research
In this Journal, Tang et al. have report the symptoms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection appear very similar to influenza (1). We would like to share our findings for co-infection of SARS-CoV-2 and influenza virus. In December, 2019, a novel coronavirus (SARS-CoV-2) caused Coronavirus disease 2019 (COVID-19) in Wuhan City, Hubei province, China (2, 3). The epidemic of SARS-CoV-2 has rapidly spread worldwide and affected more than 4 million patients with more than 300  000 deaths in more than 230 countries (4).
Source: Journal of Infection - Category: Infectious Diseases Authors: Tags: Letter to the Editor Source Type: research
Conclusions and Relevance: Because there are 74.0 million children 0 to 17 years old in the United States, the projected numbers of severe cases could overextend available pediatric hospital care resources under several moderate CPIP scenarios for 2020 despite lower severity of COVID-19 in children than in adults.
Source: Journal of Public Health Management and Practice - Category: Health Management Tags: Research Reports: Research Full Report Source Type: research
Study raises hope of immunity even for those without severe symptomsCoronavirus – latest updatesSee all our coronavirus coverageA medical study in France suggests even mild cases of coronavirus infection, not requiring hospital treatment, produce antibodies in almost all patients, with the body ’s defences against the virus increasing during the weeks of recovery.The research, led by a team from the Pasteur Institute, raises hopes that everyone who has had the disease could acquire some degree of immunity, although it is not clear for how long or to what degree.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus outbreak Medical research Immunology France Sars Biochemistry and molecular biology Epidemics Infectious diseases Europe World news Microbiology Science Source Type: news
More News: Academia | Coronavirus | COVID-19 | Epidemics | Epidemiology | International Medicine & Public Health